GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2026)

GoodRx Holdings has disclosed Free Cash Flow across 8 years of filings, most recently posting $66.8 million for Q2 2026.

• In Q2 2026, Free Cash Flow rose 110.98% year-over-year to $66.8 million; the TTM figure through Jun 2026 stood at $136.2 million (up 14.44% YoY), while the FY2025 annual figure was $97.4 million, down 15.14% from the prior year.
• Free Cash Flow came in at $66.8 million for Q2 2026 at GoodRx Holdings, up from -$8.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $71.4 million in Q3 2024 to a low of -$12.3 million in Q1 2025.
• Average Free Cash Flow over 5 years is $25.0 million, with a median of $20.0 million recorded in 2022.
• Year-over-year, Free Cash Flow soared 729.99% in 2024 and sank 155.06% in 2025.
• Over 5 years, Free Cash Flow stood at $16.7 million in 2022, then sank by 79.66% to $3.4 million in 2023, then soared by 729.99% to $28.3 million in 2024, then sank by 35.25% to $18.3 million in 2025, then jumped by 264.97% to $66.8 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $66.8 million in Q2 2026, -$8.7 million in Q1 2026, and $18.3 million in Q4 2025.